500 related articles for article (PubMed ID: 11011012)
1. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
[TBL] [Abstract][Full Text] [Related]
2. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
Rossier G; Meier C; Bauch C; Summa V; Sordat B; Verrey F; Kühn LC
J Biol Chem; 1999 Dec; 274(49):34948-54. PubMed ID: 10574970
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of
Lee KE; Kang YS
J Biomed Sci; 2017 May; 24(1):28. PubMed ID: 28490336
[TBL] [Abstract][Full Text] [Related]
4. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
Bröer A; Friedrich B; Wagner CA; Fillon S; Ganapathy V; Lang F; Bröer S
Biochem J; 2001 May; 355(Pt 3):725-31. PubMed ID: 11311135
[TBL] [Abstract][Full Text] [Related]
5. The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective cation channel that is regulated by the serine/threonine kinase sgk-1.
Wagner CA; Bröer A; Albers A; Gamper N; Lang F; Bröer S
J Physiol; 2000 Jul; 526 Pt 1(Pt 1):35-46. PubMed ID: 10878097
[TBL] [Abstract][Full Text] [Related]
6. Expression of a system L neutral amino acid transporter at the blood-brain barrier.
Matsuo H; Tsukada S; Nakata T; Chairoungdua A; Kim DK; Cha SH; Inatomi J; Yorifuji H; Fukuda J; Endou H; Kanai Y
Neuroreport; 2000 Nov; 11(16):3507-11. PubMed ID: 11095508
[TBL] [Abstract][Full Text] [Related]
7. The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine.
Bröer A; Wagner CA; Lang F; Bröer S
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):787-95. PubMed ID: 10903140
[TBL] [Abstract][Full Text] [Related]
8. Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.
Kido Y; Tamai I; Uchino H; Suzuki F; Sai Y; Tsuji A
J Pharm Pharmacol; 2001 Apr; 53(4):497-503. PubMed ID: 11341366
[TBL] [Abstract][Full Text] [Related]
9. Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.
Rajan DP; Kekuda R; Huang W; Devoe LD; Leibach FH; Prasad PD; Ganapathy V
Biochim Biophys Acta; 2000 Jan; 1463(1):6-14. PubMed ID: 10631289
[TBL] [Abstract][Full Text] [Related]
10. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).
Kanai Y; Segawa H; Miyamoto Ki; Uchino H; Takeda E; Endou H
J Biol Chem; 1998 Sep; 273(37):23629-32. PubMed ID: 9726963
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria.
Rajan DP; Kekuda R; Huang W; Wang H; Devoe LD; Leibach FH; Prasad PD; Ganapathy V
J Biol Chem; 1999 Oct; 274(41):29005-10. PubMed ID: 10506149
[TBL] [Abstract][Full Text] [Related]
12. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
[TBL] [Abstract][Full Text] [Related]
13. Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.
Pfeiffer R; Rossier G; Spindler B; Meier C; Kühn L; Verrey F
EMBO J; 1999 Jan; 18(1):49-57. PubMed ID: 9878049
[TBL] [Abstract][Full Text] [Related]
14. Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature.
Killian DM; Chikhale PJ
Neurosci Lett; 2001 Jun; 306(1-2):1-4. PubMed ID: 11403943
[TBL] [Abstract][Full Text] [Related]
15. High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells.
Soares-da-Silva P; Serrão MP
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F252-61. PubMed ID: 15271688
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of the large neutral amino acid transporter at the blood-brain barrier.
Boado RJ; Li JY; Nagaya M; Zhang C; Pardridge WM
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12079-84. PubMed ID: 10518579
[TBL] [Abstract][Full Text] [Related]
17. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
Yanagida O; Kanai Y; Chairoungdua A; Kim DK; Segawa H; Nii T; Cha SH; Matsuo H; Fukushima J; Fukasawa Y; Tani Y; Taketani Y; Uchino H; Kim JY; Inatomi J; Okayasu I; Miyamoto K; Takeda E; Goya T; Endou H
Biochim Biophys Acta; 2001 Oct; 1514(2):291-302. PubMed ID: 11557028
[TBL] [Abstract][Full Text] [Related]
18. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
[TBL] [Abstract][Full Text] [Related]
19. Apical and basolateral 4F2hc and the amino acid exchange of L-DOPA in renal LLC-PK1 cells.
Soares-da-Silva P; Serrão MP
Amino Acids; 2005 Nov; 29(3):213-9. PubMed ID: 16136276
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
